US3800378A
(en)
*
|
1972-06-07 |
1974-04-02 |
Rca Corp |
Method of making a directly-heated cathode
|
US4442113A
(en)
*
|
1981-05-07 |
1984-04-10 |
A/S Ferrosan |
Long-term weight reduction of obese patients using femoxetine
|
US4485109A
(en)
*
|
1982-05-07 |
1984-11-27 |
E. I. Du Pont De Nemours And Company |
4-Aryl-4-piperidinecarbinols
|
DK149624C
(da)
*
|
1983-03-07 |
1987-02-02 |
Ferrosan As |
Fremgangsmaade til fremstilling af (+)-trans-3-((4-methoxyphenoxy)-methyl)-1-methyl-4-phenylpiperidin eller et farmaceutisk acceptabelt salt heraf ud fra en blanding af enantiomererne
|
US4585777A
(en)
*
|
1984-02-07 |
1986-04-29 |
A/S Ferrosan |
(-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
|
US4593036A
(en)
*
|
1984-02-07 |
1986-06-03 |
A/S Ferrosan |
(-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidine useful as 5-HT potentiator
|
GB8430581D0
(en)
*
|
1984-12-04 |
1985-01-09 |
Ferrosan As |
Treatment
|
EP0190496A3
(en)
*
|
1984-12-13 |
1987-05-27 |
Beecham Group Plc |
Piperidine derivatives having a gastro-intestinal activity
|
EP0223334B1
(en)
*
|
1985-08-10 |
1991-07-10 |
Beecham Group Plc |
Process for the preparation of aryl-piperidine carbinols
|
GB8520154D0
(en)
*
|
1985-08-10 |
1985-09-18 |
Beecham Group Plc |
Chemical process
|
NO158038C
(no)
*
|
1985-10-21 |
1988-06-29 |
Standard Tel Kabelfab As |
Kabel.
|
ES2058061T3
(es)
*
|
1985-10-25 |
1994-11-01 |
Beecham Group Plc |
Derivado de piperidina, su preparacion y su uso como medicamento.
|
DK231088D0
(da)
*
|
1988-04-28 |
1988-04-28 |
Ferrosan As |
Piperidinforbindelser, deres fremstilling og anvendelse
|
IE66332B1
(en)
*
|
1986-11-03 |
1995-12-27 |
Novo Nordisk As |
Piperidine compounds and their preparation and use
|
US5017585A
(en)
*
|
1986-11-03 |
1991-05-21 |
Novo Nordisk A/S |
Method of treating calcium overload
|
GB8626936D0
(en)
*
|
1986-11-11 |
1986-12-10 |
Ferrosan As |
Treatment
|
DK588289D0
(da)
*
|
1989-11-22 |
1989-11-22 |
Ferrosan As |
Ny heterocyklisk kemi
|
DK640289D0
(da)
*
|
1989-12-18 |
1989-12-18 |
Ferrosan As |
Ny heterocyklisk kemi
|
IL98757A
(en)
*
|
1990-07-18 |
1997-01-10 |
Novo Nordisk As |
Piperidine derivatives their preparation and pharmaceutical compositions containing them
|
KR930702000A
(ko)
*
|
1990-11-24 |
1993-09-08 |
데이빗 로버츠 |
노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
|
DE4112353A1
(de)
*
|
1991-04-16 |
1992-10-22 |
Basf Ag |
1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung
|
US5512584A
(en)
*
|
1991-04-16 |
1996-04-30 |
Basf Aktiengesellschaft |
1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
|
GB9209687D0
(en)
*
|
1992-05-06 |
1992-06-17 |
Smithkline Beecham Plc |
Novel process
|
US5258517A
(en)
*
|
1992-08-06 |
1993-11-02 |
Sepracor, Inc. |
Method of preparing optically pure precursors of paroxetine
|
GB9305175D0
(en)
*
|
1993-03-13 |
1993-04-28 |
Smithkline Beecham Plc |
Novel process
|
US5276042A
(en)
*
|
1993-04-16 |
1994-01-04 |
Crenshaw Roger T |
Treatment of premature ejaculation
|
EP0639568A1
(en)
*
|
1993-08-19 |
1995-02-22 |
Novo Nordisk A/S |
Piperidine compounds, their preparation and use in the treatment of neurodegenerative disorders
|
US5446057A
(en)
*
|
1993-09-24 |
1995-08-29 |
Warner-Lambert Company |
Substituted tetrahydropyridine and piperidine carboxylic acids as muscarinic antagonists
|
US20020086053A1
(en)
*
|
1993-12-15 |
2002-07-04 |
Smithkline Beecham Plc |
Formulations, tablets of paroxetine and process to prepare them
|
GB9402029D0
(en)
*
|
1994-02-03 |
1994-03-30 |
Smithkline Beecham Plc |
Novel formulation
|
ES2102295B1
(es)
*
|
1994-03-18 |
1998-04-01 |
Ferrer Int |
Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
|
US5856493A
(en)
*
|
1995-02-06 |
1999-01-05 |
Smithkline Beecham Corporation |
Process for making novel form of paroxeting hydrochloride anhydrate
|
SK283608B6
(sk)
*
|
1995-02-06 |
2003-10-07 |
Smithkline Beecham Plc |
Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
|
WO1996036636A1
(en)
*
|
1995-05-17 |
1996-11-21 |
Novo Nordisk A/S |
Process for preparing 4-aryl-piperidine derivatives
|
US6548084B2
(en)
*
|
1995-07-20 |
2003-04-15 |
Smithkline Beecham Plc |
Controlled release compositions
|
ATE192042T1
(de)
*
|
1995-08-16 |
2000-05-15 |
Lilly Co Eli |
Potenzierung von serotonin-wirkstoffresponz
|
NZ315677A
(en)
*
|
1995-09-07 |
2000-02-28 |
F |
4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
|
ZA9610738B
(en)
*
|
1995-12-22 |
1997-06-24 |
Warner Lambert Co |
Subtype selective nmda receptor ligands and the use thereof
|
GB9526645D0
(en)
*
|
1995-12-28 |
1996-02-28 |
Chiroscience Ltd |
Stereoselective synthesis
|
GB9605828D0
(en)
*
|
1996-03-20 |
1996-05-22 |
Smithkline Beecham Plc |
Treatment method
|
ES2121685B1
(es)
*
|
1996-04-10 |
1999-09-16 |
Vita Invest Sa |
Procedimiento para la obtencion de (+)-trans-4(4-fluoro-fenil)-3-hidroximetil-1-metilpiperidina.
|
JP3446468B2
(ja)
|
1996-04-15 |
2003-09-16 |
旭硝子株式会社 |
ピペリジンカルビノール類の製造方法
|
CA2206592A1
(en)
*
|
1996-05-30 |
1997-11-30 |
Shu-Zhong Wang |
Method of producing amorphous paroxetine hydrochloride
|
JP3882224B2
(ja)
*
|
1996-05-31 |
2007-02-14 |
旭硝子株式会社 |
パロキセチンの製造方法
|
EP1384711A1
(en)
|
1996-06-13 |
2004-01-28 |
SUMIKA FINE CHEMICALS Co., Ltd. |
Optical resolution of a piperidine derivative
|
HU221921B1
(hu)
*
|
1996-07-08 |
2003-02-28 |
Richter Gedeon Vegyészeti Gyár Rt. |
N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
|
US6638948B1
(en)
|
1996-09-09 |
2003-10-28 |
Pentech Pharmaceuticals, Inc. |
Amorphous paroxetine composition
|
US5672612A
(en)
*
|
1996-09-09 |
1997-09-30 |
Pentech Pharmaceuticals, Inc. |
Amorphous paroxetine composition
|
GB9623359D0
(en)
*
|
1996-11-09 |
1997-01-08 |
Smithkline Beecham Plc |
Novel process
|
GB9700690D0
(en)
*
|
1997-01-15 |
1997-03-05 |
Smithkline Beecham Plc |
Novel process
|
AU744259B2
(en)
|
1997-04-07 |
2002-02-21 |
Gian Luca Araldi |
Analogs of cocaine
|
GB9710004D0
(en)
|
1997-05-17 |
1997-07-09 |
Knoll Ag |
Chemical process
|
AP9901698A0
(en)
*
|
1997-05-29 |
1999-12-31 |
Smithkline Beecham Corp |
Novel process.
|
CN1092654C
(zh)
*
|
1997-06-10 |
2002-10-16 |
斯索恩有限公司 |
4-苯基哌啶类化合物
|
SI0994872T1
(es)
*
|
1997-06-10 |
2001-08-31 |
Synthon Bv |
|
CA2212451C
(en)
*
|
1997-08-07 |
2001-10-02 |
Brantford Chemicals Inc. |
Stereoselective and useful preparation of 3-substituted 4-aryl piperidine compounds
|
ES2137131B1
(es)
*
|
1998-02-06 |
2000-09-16 |
Vita Invest Sa |
Derivado de piperidinona procedimiento de obtencion y procedimiento para su utilizacion.
|
PL342931A1
(en)
*
|
1998-03-16 |
2001-07-16 |
Smithkline Beecham Plc |
Crystalline form of paroxetine
|
GB9806312D0
(en)
*
|
1998-03-24 |
1998-05-20 |
Smithkline Beecham Plc |
Novel formulations
|
US6528529B1
(en)
|
1998-03-31 |
2003-03-04 |
Acadia Pharmaceuticals Inc. |
Compounds with activity on muscarinic receptors
|
JP2002511466A
(ja)
*
|
1998-04-09 |
2002-04-16 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
マレイン酸パロキセチン
|
GB9808896D0
(en)
*
|
1998-04-25 |
1998-06-24 |
Smithkline Beecham Plc |
Novel compound
|
DE69910691T2
(de)
|
1998-06-29 |
2004-07-08 |
Sumika Fine Chemical Co. Ltd. |
L-Tartrate von Trans-(-)-4-(4-Fluorphenyl)-3-Hydroxymethyl-Piperidin Verbindungen und Verfahren zu ihrer Herstellung
|
CH689805A8
(fr)
*
|
1998-07-02 |
2000-02-29 |
Smithkline Beecham Plc |
Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
|
ES2138937B1
(es)
|
1998-07-07 |
2000-10-01 |
Medichem Sa |
Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
|
EA200100221A1
(ru)
*
|
1998-08-07 |
2001-08-27 |
Смитклайн Бичам Плс |
Способ получения некристаллической негидратной формы гидрохлорида пароксетина
|
AU769260B2
(en)
|
1998-10-07 |
2004-01-22 |
Georgetown University |
Monomeric and dimeric heterocycles, and therapeutic uses thereof
|
GB9826242D0
(en)
*
|
1998-11-30 |
1999-01-20 |
Smithkline Beecham Plc |
Novel process
|
GB9826171D0
(en)
*
|
1998-11-30 |
1999-01-20 |
Smithkline Beecham Plc |
Novel compounds
|
GB9826178D0
(en)
*
|
1998-11-30 |
1999-01-20 |
Smithkline Beecham Plc |
Novel process
|
DE69913377T2
(de)
*
|
1998-11-30 |
2004-12-30 |
Smithkline Beecham P.L.C., Brentford |
Gemischte Paroxetin-Propan-2-ol-Solvate
|
GB9827387D0
(en)
*
|
1998-12-11 |
1999-02-03 |
Smithkline Beecham Plc |
Novel process
|
EP1140832A4
(en)
*
|
1998-12-22 |
2004-11-03 |
Pentech Pharmaceuticals Inc |
PROCESS FOR THE PREPARATION OF INTERMEDIATES AND DERIVATIVES OF ARYLPIPERIDINE CARBINOL
|
GB9828767D0
(en)
*
|
1998-12-29 |
1999-02-17 |
Smithkline Beecham Plc |
Novel process
|
GB9914583D0
(en)
*
|
1999-06-22 |
1999-08-25 |
Smithkline Beecham Plc |
Novel process
|
GB9915303D0
(en)
*
|
1999-06-30 |
1999-09-01 |
Smithkline Beecham Plc |
Novel process
|
WO2001002393A1
(en)
*
|
1999-07-01 |
2001-01-11 |
Italfarmaco S.P.A. |
Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
|
GB9915727D0
(en)
*
|
1999-07-03 |
1999-09-08 |
Smithkline Beecham Plc |
Novel compound and process
|
GB9916187D0
(en)
*
|
1999-07-09 |
1999-09-08 |
Smithkline Beecham Plc |
Novel process
|
GB9916392D0
(en)
*
|
1999-07-13 |
1999-09-15 |
Smithkline Beecham Plc |
Novel process
|
IT1313702B1
(it)
|
1999-08-02 |
2002-09-09 |
Chemi Spa |
Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
|
GB9919052D0
(en)
*
|
1999-08-12 |
1999-10-13 |
Smithkline Beecham Plc |
Novel compound composition and process
|
GB9920147D0
(en)
*
|
1999-08-25 |
1999-10-27 |
Smithkline Beecham Plc |
Novel process
|
GB9923539D0
(en)
*
|
1999-10-05 |
1999-12-08 |
Smithkline Beecham Plc |
Novel process
|
GB9923540D0
(en)
*
|
1999-10-05 |
1999-12-08 |
Smithkline Beecham Plc |
Novel process
|
GB9924882D0
(en)
*
|
1999-10-20 |
1999-12-22 |
Smithkline Beecham Plc |
Novel process
|
WO2001029002A1
(en)
*
|
1999-10-20 |
2001-04-26 |
Smithkline Beecham Plc |
Process for the preparation of 4-(fluorophenyl)piperidine esters
|
GB9924855D0
(en)
*
|
1999-10-20 |
1999-12-22 |
Smithkline Beecham Plc |
Novel processes
|
US6503927B1
(en)
|
1999-10-28 |
2003-01-07 |
Pentech Pharmaceuticals, Inc. |
Amorphous paroxetine composition
|
US6380200B1
(en)
|
1999-12-07 |
2002-04-30 |
Pfizer, Inc. |
Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications
|
HU226912B1
(en)
*
|
2000-04-07 |
2010-03-01 |
Richter Gedeon Nyrt |
New paroxetin salt and medicament containing it
|
WO2001085688A1
(en)
*
|
2000-05-12 |
2001-11-15 |
Synthon B.V. |
TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
|
US6833458B2
(en)
|
2000-06-05 |
2004-12-21 |
Development Center For Biotechnology |
Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
|
WO2002006275A1
(en)
*
|
2000-07-17 |
2002-01-24 |
Smithkline Beecham P.L.C. |
Novel processes for the preparation of 4-phenylpiperidine derivatives
|
GB0021147D0
(en)
*
|
2000-08-30 |
2000-10-11 |
Knoll Ag |
Chemical process
|
GB0021145D0
(en)
*
|
2000-08-30 |
2000-10-11 |
Knoll Ag |
Chemical process
|
WO2002028834A1
(en)
*
|
2000-10-06 |
2002-04-11 |
Smithkline Beecham P.L.C. |
Process for the preparation of aryl-piperidine carbinols and intermediates thereof
|
WO2002032870A1
(en)
*
|
2000-10-20 |
2002-04-25 |
Smithkline Beecham P.L.C. |
Process of the preparation of 3-substituted-4-aryl piperidine compounds
|
EP1347960B1
(en)
*
|
2001-01-04 |
2004-11-17 |
Ferrer Internacional, S.A. |
Process for preparing (+) trans-4-p-fluorophenyl-3-hydroxymethyl-1
|
DE20100529U1
(de)
*
|
2001-01-11 |
2001-05-10 |
Synthon Bv |
Pharmazeutische Tablette umfassend Paroxetinmesylat
|
US6777554B2
(en)
|
2001-02-05 |
2004-08-17 |
Teva Pharmaceutical Industries Ltd. |
Preparation of N-methylparoxetine and related intermediate compounds
|
US6720003B2
(en)
*
|
2001-02-16 |
2004-04-13 |
Andrx Corporation |
Serotonin reuptake inhibitor formulations
|
NL1017421C2
(nl)
*
|
2001-02-21 |
2002-01-15 |
Synthon Bv |
Werkwijze voor het vervaardigen van paroxetine.
|
CA2438892A1
(en)
*
|
2001-02-24 |
2002-09-06 |
Spurcourt Limited |
Process of preparing paroxetine and intermediates for use therein
|
US6645946B1
(en)
|
2001-03-27 |
2003-11-11 |
Pro-Pharmaceuticals, Inc. |
Delivery of a therapeutic agent in a formulation for reduced toxicity
|
WO2002100829A2
(en)
*
|
2001-06-13 |
2002-12-19 |
Teva Pharmaceutical Industries Ltd. |
Process for the preparation of paroxetine substantially free of alkoxy impurities
|
EP1412350A1
(en)
*
|
2001-08-02 |
2004-04-28 |
Spurcourt Limited |
Paroxetine isethionate salt, process of preparation and use in the treatment of depression
|
AU2002342045C1
(en)
*
|
2001-10-12 |
2009-07-30 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl vasopressin Vla antagonists
|
IL161521A0
(en)
*
|
2001-10-22 |
2004-09-27 |
Synthon Bv |
N-formyl derivatives of paroxetine
|
CA2471715A1
(en)
*
|
2001-12-28 |
2003-07-17 |
Teva Pharmaceutical Industries Ltd. |
A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
|
US6956121B2
(en)
|
2002-03-01 |
2005-10-18 |
Teva Pharmaceutical Industries Ltd. |
Preparation of paroxetine involving novel intermediates
|
US7138523B2
(en)
*
|
2002-05-16 |
2006-11-21 |
Apotex Pharmachem Inc. |
Preparation of 4-(4-fluorophenyl)-N-alkylnipecotinate esters, 4-(4-fluorophenyl)-N-arylnipecotinate esters and 4-(4-fluorophenyl)-N-aralkylnipecotinate esters
|
KR100477048B1
(ko)
*
|
2002-07-05 |
2005-03-17 |
임광민 |
피페리딘 화합물의 새로운 제조방법
|
US7560562B2
(en)
*
|
2002-11-01 |
2009-07-14 |
Neurosearch A/S |
Piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
|
WO2004043921A1
(en)
*
|
2002-11-11 |
2004-05-27 |
Natco Pharma Limited |
Novel process for the preparation of 4-aryl-3-hydroxymethyl-1-methylpiperidines.
|
UA82698C2
(uk)
|
2003-05-30 |
2008-05-12 |
Ранбакси Лабораториз Лимитед |
Заміщені похідні піролу та їх використання в якості інгібіторів hmg-co
|
CA2537402C
(en)
|
2003-09-12 |
2009-05-05 |
Pfizer Inc. |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
|
ES2319539T3
(es)
*
|
2003-09-17 |
2009-05-08 |
Janssen Pharmaceutica Nv |
Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
DK1689721T3
(da)
*
|
2003-11-26 |
2010-09-20 |
Pfizer Prod Inc |
Aminopyrazolderivater som GSK-3-ihibitorer
|
WO2005060968A1
(en)
|
2003-12-11 |
2005-07-07 |
Sepracor Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
WO2005102366A2
(en)
*
|
2004-04-19 |
2005-11-03 |
Philip Maxwell Satow |
Lithium combinations, and uses related thereto
|
PE20060437A1
(es)
|
2004-06-18 |
2006-06-08 |
Novartis Ag |
COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
|
GB0415746D0
(en)
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
WO2006018318A1
(en)
*
|
2004-08-18 |
2006-02-23 |
Synthon B.V. |
Liquid paroxetine compositions
|
WO2006023347A1
(en)
*
|
2004-08-20 |
2006-03-02 |
Alpharma, Inc. |
Paroxetine formulations
|
JP2008534504A
(ja)
|
2005-03-22 |
2008-08-28 |
アゼヴァン ファーマスーティカルズ,インコーポレイテッド |
月経前障害を治療するためのβラクタミルアルカン酸
|
GB0507298D0
(en)
|
2005-04-11 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
CN101203218A
(zh)
*
|
2005-04-22 |
2008-06-18 |
惠氏公司 |
苯并呋喃基链烷胺衍生物和其作为5-ht2c激动剂的用途
|
CN101175740A
(zh)
|
2005-04-22 |
2008-05-07 |
惠氏公司 |
二氢苯并呋喃衍生物和其用途
|
JP2008538577A
(ja)
*
|
2005-04-22 |
2008-10-30 |
ワイス |
ジヒドロベンゾフラン誘導体およびその使用
|
JP2008538581A
(ja)
*
|
2005-04-22 |
2008-10-30 |
ワイス |
{[(2r)−7−(2,6−ジクロロフェニル)−5−フルオロ−2,3−ジヒドロ−1−ベンゾフラン−2−イル]メチル}アミン塩酸塩の結晶形態
|
US20060264637A1
(en)
*
|
2005-05-16 |
2006-11-23 |
Thippannachar Vijayavitthal M |
Preparation of paroxetine hydrochloride hemihydrate
|
US20070015138A1
(en)
*
|
2005-07-08 |
2007-01-18 |
Braincells, Inc. |
Methods for identifying agents and conditions that modulate neurogenesis
|
DK1910346T3
(da)
|
2005-07-19 |
2019-05-27 |
Azevan Pharmaceuticals Inc |
Beta-lactamyl fenylalanin, cystein og serin vasopressin antagonist
|
BRPI0615973A2
(pt)
*
|
2005-07-29 |
2011-05-31 |
Concert Pharmaceuticals Inc |
novos derivados de benzo [d] [1,3] - dioxol
|
US7598255B2
(en)
|
2005-08-04 |
2009-10-06 |
Janssen Pharmaceutica Nv |
Pyrimidine compounds as serotonin receptor modulators
|
EP2377530A3
(en)
|
2005-10-21 |
2012-06-20 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
WO2007053596A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
WO2007054896A1
(en)
|
2005-11-08 |
2007-05-18 |
Ranbaxy Laboratories Limited |
Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
CN101355876B
(zh)
|
2005-11-09 |
2012-09-05 |
康宾纳特克斯公司 |
一种适用于眼部给药的组合物
|
AU2006315684A1
(en)
*
|
2005-11-14 |
2007-05-24 |
Auspex Pharmaceuticals, Inc. |
Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
|
GB0525672D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
GB0525673D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
US20070142389A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Pfizer Inc. |
Piperidine derivatives
|
FR2912057B1
(fr)
*
|
2007-02-07 |
2009-04-17 |
Sanofi Aventis Sa |
Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
|
AU2007223036A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
US20100216734A1
(en)
*
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
RU2008135326A
(ru)
*
|
2006-03-24 |
2010-04-27 |
Вайет (Us) |
Терапевтические композиции для лечения депрессии
|
US7858611B2
(en)
*
|
2006-05-09 |
2010-12-28 |
Braincells Inc. |
Neurogenesis by modulating angiotensin
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
EP2026813A2
(en)
*
|
2006-05-09 |
2009-02-25 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
JP2009536669A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス,インコーポレイティド |
アンジオテンシン調節による神経新生
|
TW200817003A
(en)
*
|
2006-07-31 |
2008-04-16 |
Sanofi Aventis |
Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
|
US20080033050A1
(en)
|
2006-08-04 |
2008-02-07 |
Richards Patricia Allison Tewe |
Method of treating thermoregulatory disfunction with paroxetine
|
KR20090064418A
(ko)
|
2006-09-08 |
2009-06-18 |
브레인셀즈 인코퍼레이션 |
4-아실아미노피리딘 유도체 포함 조합물
|
WO2008034032A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Azevan Pharmaceuticals, Inc. |
Beta-lactam cannabinoid receptor modulators
|
CA2663347A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
Ppar mediated modulation of neurogenesis
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
US20080167363A1
(en)
*
|
2006-12-28 |
2008-07-10 |
Braincells, Inc |
Modulation of Neurogenesis By Melatoninergic Agents
|
WO2008086483A2
(en)
*
|
2007-01-11 |
2008-07-17 |
Braincells, Inc. |
Modulation of neurogenesis with use of modafinil
|
AU2008279447A1
(en)
|
2007-07-19 |
2009-01-29 |
Metabolex, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
|
CA2698808A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
|
US9138430B2
(en)
*
|
2007-12-27 |
2015-09-22 |
Mylan Specialty L.P. |
Formulation and method for the release of paroxetine in the large intestine
|
WO2009128058A1
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
JP2011524917A
(ja)
*
|
2008-06-20 |
2011-09-08 |
メタボレックス, インコーポレイテッド |
アリールgpr119作動薬およびその使用
|
CA2742114C
(en)
|
2008-11-14 |
2016-09-13 |
Theravance, Inc. |
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
ES2497566T3
(es)
|
2009-10-01 |
2014-09-23 |
Cymabay Therapeutics, Inc. |
Sales de tetrazol-1-il-fenoximetil-tiazol-2-il-piperidinil-pirimidina sustituida
|
EP2523945A1
(en)
*
|
2010-01-11 |
2012-11-21 |
Theravance, Inc. |
1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors
|
EP2550252B1
(en)
*
|
2010-03-22 |
2015-05-06 |
Theravance Biopharma R&D IP, LLC |
1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
|
CA2802541A1
(en)
|
2010-06-23 |
2011-12-29 |
Metabolex, Inc. |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
US9376424B2
(en)
|
2010-07-01 |
2016-06-28 |
Azevan Pharmaceuticals, Inc. |
Methods for treating post traumatic stress disorder
|
JP2014508187A
(ja)
|
2011-03-17 |
2014-04-03 |
ルピン・リミテッド |
選択的セロトニン再取り込み阻害薬の放出制御医薬組成物
|
TW201334783A
(zh)
|
2012-01-31 |
2013-09-01 |
Eisai R&D Man Co Ltd |
帕羅西汀(Paroxetine)衍生物
|
JP7255967B2
(ja)
|
2014-03-28 |
2023-04-11 |
アゼヴァン ファーマスーティカルズ,インコーポレイテッド |
神経変性疾患を治療するための組成物および方法
|
EP3493807A1
(en)
|
2016-08-03 |
2019-06-12 |
CymaBay Therapeutics, Inc. |
Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
|
BR112020005107A2
(pt)
|
2017-09-15 |
2020-11-03 |
Azevan Pharmaceuticals, Inc. |
composições e métodos para o tratamento de lesão cerebral
|
WO2023102477A1
(en)
*
|
2021-12-02 |
2023-06-08 |
The Johns Hopkins University |
Peripherally and luminally-restricted inhibitors of the serotonin transporter as treatments for disorders of gastrointestinal motility
|